Is Trigyn Techno. overvalued or undervalued?

As of 4 July 2025, Trigyn Techno. has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its financial metrics. The PE ratio stands at 22.15, while the EV to EBITDA ratio is at -7.81, indicating negative earnings before interest, taxes, depreciation, and amortization. Additionally, the ROE is a mere 1.60%, which raises concerns about the company's profitability relative to its equity.
In comparison to its peers, Trigyn Techno. has a PE ratio lower than TCS (25.49) and Infosys (25.51), both of which are performing better in the market. HCL Technologies also shows a more favorable PE of 26.94. Notably, Trigyn's negative EV to EBIT and EV to Sales ratios further highlight its struggles compared to these competitors. Furthermore, the company's stock has underperformed significantly over the past year, with a decline of 38.06% compared to a 4.23% increase in the Sensex, reinforcing the notion that it is overvalued at its current price of 85.13.